European Leukemia Trial Registry
Trial: AML WT1-Vaccination

More Details
Scientific Title WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
Short Title AML WT1-Vaccination
Trialgroup NN
Type of Trial multicentric, single-group
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Closed
Start of Recruitment 01.04.2002
Leader Keilholz, Prof. Dr. med., Ulrich
Contactperson

Study Physician
Scheibenbogen, Prof. Dr. med., Carmen
Tel: +49 (0)30 8445 3596
Email: carmen.scheibenbogen@charite.de

Centre of Trial Charité Universitätsmedizin Berlin, Campus Benjamin Franklin
Shortprotocol Shortprotocol
created 04.07.2006 Anja Hellenbrecht
changed 23.10.2008 5 Roswitha Kotthoff
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org